Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo

Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer

(2019) Weimin Xu et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

IMP3 expression in biopsy specimens as a diagnostic biomarker for colorectal cancer

(2017) Qingzhu Wei et al.   HUMAN PATHOLOGY

What We Know About Stage II and III Colon Cancer: It’s Still Not Enough

(2017) Alberto Puccini et al.   Targeted Oncology

Long-term quality of life associated with early surgical complications in patients with ulcerative colitis after ileal pouch–anal anastomosis: A single-center retrospective study

(2017) Weimin Xu et al.   International Journal of Surgery

Blood Measurement of Carcinoembryonic Antigen Level for Detecting Recurrence of Colorectal Cancer

(2016) Brian D. Nicholson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Surveillance after curative treatment for colorectal cancer

(2016) Eric P. van der Stok et al.   Nature Reviews Clinical Oncology

The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer

(2014) Marcell Lederer et al.   SEMINARS IN CANCER BIOLOGY

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer

(2012) Paul Lochhead et al.   EUROPEAN JOURNAL OF CANCER

Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression

(2012) Elena M Hartmann et al.   MODERN PATHOLOGY

Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer

(2012) S Samanta et al.   ONCOGENE

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

(2011) Greg Yothers et al.   JOURNAL OF CLINICAL ONCOLOGY

The social aspects of EMT-MET plasticity

(2011) E W Thompson et al.   NATURE MEDICINE

Has the new TNM classification for colorectal cancer improved care?

(2011) Iris D. Nagtegaal et al.   Nature Reviews Clinical Oncology

Diffuse Expression of RNA-Binding Protein IMP3 Predicts High-Stage Lymph Node Metastasis and Poor Prognosis in Colorectal Adenocarcinoma

(2009) Ray-Hwang Yuan et al.   ANNALS OF SURGICAL ONCOLOGY

IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

(2009) Dawei Li et al.   ANNALS OF SURGICAL ONCOLOGY

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype

(2009) Martin Köbel et al.   MODERN PATHOLOGY

IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder

(2008) L. Sitnikova et al.   CLINICAL CANCER RESEARCH

RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma

(2008) Yung-Ming Jeng et al.   HEPATOLOGY